Agarwal Medilife Distributors Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 06-07-2024
- Paid Up Capital ₹ 2.31 M
as on 06-07-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.18 M
as on 06-07-2024
- Revenue 21.53%
(FY 2022)
- Profit 22.32%
(FY 2022)
- Ebitda -1125.01%
(FY 2022)
- Net Worth 1.89%
(FY 2022)
- Total Assets 35.17%
(FY 2022)
About Agarwal Medilife Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.31 M.
The company currently has active open charges totaling ₹9.18 M.
Anmol Goyal, Anil Bansal, and Rajendra Goyal serve as directors at the Company.
- CIN/LLPIN
U24232RJ2008PTC026638
- Company No.
026638
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Agarwal Medilife Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anmol Goyal  | Director | 25-Jun-2010 | Current |
| Anil Bansal | Director | 27-May-2008 | Current |
| Rajendra Goyal | Director | 27-May-2008 | Current |
Financial Performance of Agarwal Medilife Distributors.
Agarwal Medilife Distributors Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.53% increase. The company also saw a substantial improvement in profitability, with a 22.32% increase in profit. The company's net worth moved up by a moderate rise of 1.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agarwal Medilife Distributors?
In 2019, Agarwal Medilife Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Sep 2022 | ₹1.50 M | Open |
Indian Bank Creation Date: 18 Jun 2020 | ₹0.68 M | Open |
Indian Bank Creation Date: 04 Mar 2015 | ₹7.00 M | Open |
How Many Employees Work at Agarwal Medilife Distributors?
Unlock and access historical data on people associated with Agarwal Medilife Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agarwal Medilife Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agarwal Medilife Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
